John H. Leaman - 08 Mar 2026 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Director
Signature
/s/ John H. Leaman
Issuer symbol
TRAW
Transactions as of
08 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 19:20:43 UTC
Previous filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leaman John Harold Director C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTOWN /s/ John H. Leaman 10 Mar 2026 0001586657

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to buy) Award +33,435 $0.000000* 33,435 08 Mar 2026 Common Stock 33,435 $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.